|
Date: November 26, 2003 (Wednesday)
Time: 12:30 to 14:00
Venue: Seminar Room 3, G/F, Laboratory Block, Faculty of Medicine
Building, 21 Sassoon Road, Pokfulam
Professor Uma Roa's expertise lies
on identifying risk factors for smoking initiation, nicotine dependence
and non-nicotine related substance use disorders in depressed and
non-depressed adolescents. Recent research findings from Professor
Roa has shown that adolescence is a high-risk period for developing
substance use disorders and that the presence of depression is associated
with more rapid progression from experimentation to pathological
use of alcohol and other drugs during this developmental period.
The seminar will compare the risk
for developing recurrent depressive episodes and significant psychosocial
dysfunction among depressed youth who develop substance abuse with
their counterparts who do not develop substance abuse. The long-term
goal of Professor Rao is to develop and test preventive strategies
for substance use disorders in depressed and non-depressed youth.
Professor Uma Roa is Professor of
Psychiatry at The University of Texas Southwestern Medical Center
at Dallas. Professor Roa received her MBBS degrees and an MD from
the Bangalore Medical College in India, and a Post Doctoral Fellow
in Clinical Research in Child Psychiatry from the College of Physicians
& Surgeons at Columbia University.
Uma currently serves as the Medical
Director, Child and Adolescent Mood Disorders Program of the University
of California at Los Angeles Neuropsychiatric Institute and Hospital.
She was awarded the Young Investigator Award (National Alliance
for Research on Schizophrenia and Depression) for years 1999-2002.
Recent publications by Professor
Uma Roa:
Depression and Bipolar Disorder
Support Alliance (2003): Consensus Development Panel: National Depressive
and Manic-Depressive Association consensus statement on the unmet
needs in diagnosis and treatment of mood disorders in children and
adolescents, in press.
Rao U, Lin K-M, Poland RE: REM sleep
and cortisol responses to scopolamine during depression and remission
in women. International journal of Neuropsychopharmacology, in press.
Rao U, Ott GE, Lin K-M, Poland RE:
Effect of bupropion on nocturnal urinary free cortisol and its association
with antidepressant response. Journal of Psychiatric Research, in
press.
Photo Gallery
|
